Hainan Helpson Bio-pharmaceutical

Hainan Helpson Bio-Pharmaceutical is a specialty pharmaceutical company based in Haikou, China, and a wholly-owned subsidiary of China Pharma Holdings, Inc. (NYSE American: CPHI). Founded in 1993, the company integrates research, development, manufacturing, and sales of a diverse portfolio including prescription drugs, OTC products, and medical devices. Its therapeutic focus spans cardiovascular, central nervous system, infectious, and digestive diseases, with notable products like Candesartan and Tiopronin. Helpson operates a GMP-certified production facility and is expanding into medical devices, such as an oxygen-enriched atomization instrument for dry eye disease. The company also recently acquired rights to a Topiroxostat nanoemulsion for the treatment of gout and hyperuricemia.